Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

April 30, 2014

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

PDS 1.0

Trial Locations (1)

Unknown

Riga

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Forsight Vision4

INDUSTRY